| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 09/17/2009 | US20090232893 miR-143 REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENTION |
| 09/17/2009 | US20090232882 PEPTIDE BASED INHIBITION OF caPCNA INTERACTION IN CANCER |
| 09/17/2009 | US20090232854 Uses of bispecific antibody coated dendritic cells pulsed with antigens and gm-csf in immune regulation |
| 09/17/2009 | US20090232849 Methods and compositions for the treatment of cancer |
| 09/17/2009 | US20090232839 Glycoprotein-100 peptide for use as tool in treatment and diagnosis of cancer and viral infection |
| 09/17/2009 | US20090232835 Composition for delivery of hematopoietic growth factor |
| 09/17/2009 | US20090232834 Methods and Agents to Treat Autoimmune Diseases |
| 09/17/2009 | US20090232830 Modified HIV-1 Envelope Proteins |
| 09/17/2009 | US20090232826 Antibody or a fragment thereof, having neutralizing activity against hiv but not against il2 |
| 09/17/2009 | US20090232823 Anti-tyrp1 antibodies |
| 09/17/2009 | US20090232822 Lung disease targets and uses thereof |
| 09/17/2009 | US20090232818 Prognosis and Treatment of Breast Cancer |
| 09/17/2009 | US20090232816 Il-1 eta dna and polypeptides |
| 09/17/2009 | US20090232815 Monoclonal antibody or antibody fragment which binds a pleiotrophin-binding fragment of human Anaplastic Lymphoma Kinase (ALK) and inhibits a pleiotrophin-mediated activity; prevents pleiotrophin-mediated neoplastic or mitogenic activity |
| 09/17/2009 | US20090232813 Four-Jointed Box (FJX1) In Cancer Diagnosis and Treatment |
| 09/17/2009 | US20090232811 Bivalent, bispecific antibodies |
| 09/17/2009 | US20090232809 Type 2 cytokine receptor and nucleic acids encoding same |
| 09/17/2009 | US20090232804 Humanized antibodies specific for von willebrand factor |
| 09/17/2009 | US20090232803 Antibodies to human il-1beta |
| 09/17/2009 | US20090232801 Humanized Antibodies Which Bind To AB (1-42) Globulomer And Uses Thereof |
| 09/17/2009 | US20090232797 Plasmodium malariae and plasmodium ovale genes and uses thereof |
| 09/17/2009 | US20090232795 1b20 pcsk9 antagonists |
| 09/17/2009 | US20090232794 Modulators of neuronal regeneration |
| 09/17/2009 | US20090232793 Elastase inhibitor and acute leukemia |
| 09/17/2009 | US20090232791 comprising a first component comprising fibrinogen, aprotinin, and a buffered solution, and comprising, fibroblasts, keratinocytes, thrombin, glycerol, human serum albumin, and a buffered solution, wherein components are comprised in separate sterile containers |
| 09/17/2009 | US20090232783 Method for Regulating Production of Hemoglobin Beta Chains |
| 09/17/2009 | US20090232780 Compounds that enhance atoh1 expression |
| 09/17/2009 | US20090232779 Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury |
| 09/17/2009 | US20090232778 Methods and Compositions for Hair Growth |
| 09/17/2009 | US20090232777 Expansion and Differentiation of Mesenchymal Stem Cells |
| 09/17/2009 | US20090232775 Compounds and methods for increasing neurogenesis |
| 09/17/2009 | US20090232773 Method for Distinguishing Mesenchymal Stem Cell Using Molecular Marker and Use Thereof |
| 09/17/2009 | US20090232772 Human corneal endothelial cell-derived precursor cells, cellular aggregates, methods for manufacturing the same, and methods for transplanting precursor cells and cellular aggregates |
| 09/17/2009 | US20090232771 Method of controlling cell functions |
| 09/17/2009 | US20090232736 Dual specificity antibodies and methods of making and using |
| 09/17/2009 | US20090232734 Anti-tissue factor antibodies and compositions |
| 09/17/2009 | US20090232732 PRO108 Antibody Compositions and Methods of Use and Use of PRO108 to Assess Cancer Risk |
| 09/17/2009 | DE102008014041A1 Verfahren zur Erzeugung einer Breitband-Resistenz gegenüber Pilzen in transgenen Pflanzen Method for creating broad-spectrum resistance to fungi in transgenic plants |
| 09/17/2009 | DE102008013899A1 Verfahren zur Herstellung rekombinanter Proteine bei konstantem Gehalt von pCO2 im Medium A process for the production of recombinant proteins at a constant content of pCO2 in the medium |
| 09/17/2009 | CA2718495A1 Recombinant production of authentic human proteins using human cell expression systems |
| 09/17/2009 | CA2718032A1 Method for generating primate cardiovascular progenitor cells for clinical use from primate embryonic stem cells or embryonic-like state cells, and their applications |
| 09/17/2009 | CA2717197A1 Disease model incorporation into an artificial immune system (ais) |
| 09/17/2009 | CA2658074A1 Functional pigmented skin equivalent |
| 09/16/2009 | EP2100963A1 Method of vitamin production |
| 09/16/2009 | EP2100959A2 Mammalian cytokine: interleukin-B30 and related reagents |
| 09/16/2009 | EP2100954A1 Method for generating primate cardiac progenitor cells for clinical use from primate embryonic stem cells, and their applications |
| 09/16/2009 | EP2100903A2 Anti-idiotypic antibodies neutralising the inhibiting activity of an inhibiting antibody directed against domain C1 of factor VIII |
| 09/16/2009 | EP2099906A1 Compositions of and methods of using sulfatases from flavobacterium heparinum |
| 09/16/2009 | EP2099902A1 Adoptive transfer of cd8+ t cell clones derived from central memory cells |
| 09/16/2009 | EP2099901A1 Use of a composition contaning human umbilical cord blood-derived mesenchymal stem cell for inducing differentiation and proliferation of neural precursor cells or neural stem cells to neural cells |
| 09/16/2009 | EP2099900A1 Process for the enrichment of melanocytes by means of modified surfaces |
| 09/16/2009 | EP2099827A2 Antagonist anti-notch3 antibodies and their use in the prevention and treatment of notch3-related diseases |
| 09/16/2009 | EP2099491A2 Compositions and methods for diagnosing and treating cancer |
| 09/16/2009 | EP2099290A2 Method of generation and expansion of tissue-progenitor cells and mature tissue cells from intact bone marrow or intact umbilical cord tissue |
| 09/16/2009 | EP1771471B1 Genetically modified human natural killer cell lines |
| 09/16/2009 | EP1757680B1 Methods for cultivating antigen presenting cells |
| 09/16/2009 | EP1642969B1 Fluorescent protein and pigment protein |
| 09/16/2009 | EP1414948B1 Inhibition of apoptosis process and improvement of cell performance |
| 09/16/2009 | EP1399479B1 Cation conducting gaba a receptors and their use |
| 09/16/2009 | EP1377608B1 Insulin precursors and a process for their preparation |
| 09/16/2009 | EP1356064B1 Transcriptional regulator nucleic acids, polypeptides and methods of use thereof |
| 09/16/2009 | EP1266960B1 Method and apparatus for culturing cell or tissue |
| 09/16/2009 | EP1126878B1 Heparanase activity neutralizing anti-heparanase monoclonal antibody |
| 09/16/2009 | EP1100815B1 Protease susceptibility ii |
| 09/16/2009 | EP1095144B1 Enhancer elements for increased translation in plant plastids |
| 09/16/2009 | EP1027443B1 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor |
| 09/16/2009 | EP1002084B1 Mammalian cytokine: interleukin-b30 and related reagents |
| 09/16/2009 | CN101535471A Cancerous disease modifying antibodies |
| 09/16/2009 | CN101535470A Cancerous disease modifying antibodies |
| 09/16/2009 | CN101535469A Rationally designed media for cell culture |
| 09/16/2009 | CN101535468A Parthenogenic activation of human oocytes for the production of human embryonic stem cells |
| 09/16/2009 | CN101532026A Sutellaria viscidula phenyl alanine ammonialyase protein coded sequence |
| 09/16/2009 | CN101532018A Producing method of transgenic mouse containing anthropogenic proto-oncogene c-Ha-ras and application thereof |
| 09/16/2009 | CN101532016A A section of DNA molecule, recombination expression vector containing the DNA molecule and use thereof |
| 09/16/2009 | CN101532015A Anther tapetum and pollen specific efficient promoter as well as application thereof |
| 09/16/2009 | CN101531997A Method and model for high throughout screening of G protein-coupled receptor ligand |
| 09/16/2009 | CN101531996A Method for separating and purifying mesenchymal stem cells originated from formation tissue |
| 09/16/2009 | CN101531994A Preparation method of buffalo embryonic stem cell |
| 09/16/2009 | CN101531992A Prescription of rooting medium for cultivating cowberry |
| 09/16/2009 | CN101531991A Rhodida plant callus and suspension cell granule culture method |
| 09/16/2009 | CN101531990A Flax monoploid cell suspension system culture medium |
| 09/16/2009 | CN101531715A Cytokine protein family |
| 09/16/2009 | CN101531713A Bt protein Cry56Aal as well as encoding gene thereof and application thereof |
| 09/16/2009 | CN101531712A Bt protein Cry30Bal as well as encoding gene thereof and application thereof |
| 09/16/2009 | CN101531711A Bt protein Cry52Bal as well as encoding gene thereof and application thereof |
| 09/16/2009 | CN100540661C Positive monocloning method for screening transgenetic animal cell |
| 09/16/2009 | CN100540660C A transgenic mouse liver disease animal model, producing process and application thereof |
| 09/16/2009 | CN100540659C Method for culturing mouse embryo stem cell and its dedicated culture medium |
| 09/16/2009 | CN100540658C Technology for inducing embryogenic cell generation of the poplar in populus (narrow-crown poplar) |
| 09/16/2009 | CN100540657C Endothelial cells derived from primate embryonic stem cells |
| 09/15/2009 | US7589263 Inbred maize variety PHD0G |
| 09/15/2009 | US7589262 Multiple-eared inbred line of corn for production of baby corn |
| 09/15/2009 | US7589256 L450 polypeptide and nucleic acid encoding it; transgenic plant |
| 09/15/2009 | US7589252 Enhancing the level of expression of a selected heterologous protein in seeds of transgenic plants |
| 09/15/2009 | US7589186 Isolated hOAT polynucleotide |
| 09/15/2009 | US7589180 Specific binding proteins and uses thereof |
| 09/15/2009 | US7589178 Fusion polypeptide comprising fibrinopeptide A, serine protease and thrombin-cleavable sequences for use in identifying modulators for prevention and treatment of thrombotic disorders; anticoagulants |
| 09/15/2009 | US7589177 Nucleic acid molecules encoding cyclotide polypeptides and methods of use |
| 09/15/2009 | US7589174 GRP94-based compositions and methods of use thereof |
| 09/15/2009 | US7589074 Treating inflammatory joint diseases by inhibiting cadherin-11 mediated cellular function; chronic synovitis, autoimmune diseases, rheumatoid arthritis |